B. Francica

发表

Systemic Tolerance Mediated by Melanoma Brain Tumors Is Reversible by Radiotherapy and Vaccination

Christopher M. Jackson, J. Taube, P. Calabresi, 2015, Clinical Cancer Research.

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Manish R. Patel, Charles J. Vaske, Joe Y. Chang, 2016, Journal for Immunotherapy of Cancer.

Anti-IL-10–mediated Enhancement of Antitumor Efficacy of a Dendritic Cell–targeting MIP3&agr;-gp100 Vaccine in the B16F10 Mouse Melanoma Model Is Dependent on Type I Interferons

C. Drake, James T. Gordy, R. Markham, 2018, Journal of immunotherapy.

Combining Intra-Tumoral Treg Depletion with Androgen Deprivation Therapy (ADT): Pre-Clinical Activity in the Myc-CaP Model

C. Drake, A. Korman, M. Selby, 2017, Prostate Cancer and Prostatic Diseases.

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T cell immunity to tumor antigens

C. Drake, O. Lantz, L. Seymour, 2019, Nature Biotechnology.

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

C. Drake, T. DeWeese, A. Korman, 2018, Clinical Cancer Research.

TNFα and radio-resistant stromal cells are essential for therapeutic efficacy of cyclic dinucleotide STING agonists in non-immunogenic tumors

D. Pardoll, A. Marciscano, A. Ghasemzadeh, 2018 .

RELEASING THE BRAKES: STRATEGIES TO REMODEL THE TUMOR ENVIRONMENT, INCREASE IMMUNE INFILTRATE, AND INDUCE TUMOR CELL DEATH

B. Francica, Brian J. Francica, Brian Francica, 2016 .

Antibody:CD47 ratio regulates macrophage phagocytosis through competitive receptor phosphorylation

D. Fletcher, E. Schmid, B. Francica, 2020, bioRxiv.

Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity.

Yan Feng, S. Bender, Thomas E. Hudson, 2018, Cell reports.

Paucity of PD-L1 Expression in Prostate Cancer: Innate and Adaptive Immune Resistance

M. Scott Lucia, Charles G. Drake, Allison M. Martin, 2015, Prostate Cancer and Prostatic Disease.

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1–Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

C. Drake, T. DeWeese, C. Kochel, 2014, Cancer Immunology Research.

Peptide-TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T cell immunity to tumor antigens

C. Drake, O. Lantz, L. Seymour, 2019, Nature Biotechnology.

Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model

C. Drake, A. Korman, M. Selby, 2017, Prostate Cancer and Prostatic Diseases.

TNFα and Radioresistant Stromal Cells Are Essential for Therapeutic Efficacy of Cyclic Dinucleotide STING Agonists in Nonimmunogenic Tumors

C. Drake, D. Pardoll, A. Marciscano, 2018, Cancer Immunology Research.

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma

C. Drake, P. Tran, D. Pardoll, 2016, Journal of Immunotherapy for Cancer.

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma

C. Drake, P. Tran, D. Pardoll, 2015, Journal of Immunotherapy for Cancer.